44th Annual J.P. Morgan Healthcare Conference
Logotype for DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) 44th Annual J.P. Morgan Healthcare Conference summary

Event summary combining transcript, slides, and related documents.

Logotype for DENTSPLY SIRONA Inc

44th Annual J.P. Morgan Healthcare Conference summary

14 Jan, 2026

Leadership and Strategic Vision

  • New CEO with extensive medtech experience is driving a turnaround, supported by new leadership appointments including a Chief Commercial Officer, US commercial head, interim CFO, and board members with dental market expertise.

  • Focus on brand strength, customer loyalty, and an integrated portfolio to shape the future of connected dentistry.

  • Creation of a Growth and Value (Creation) Committee/Board to guide long-term strategy, capital allocation, and potential portfolio moves.

  • Emphasis on urgent execution, operational change, and embedded accountability to address underperformance and drive growth.

  • Ongoing commitment to provide updates as milestones are achieved.

Market Position and Portfolio

  • Operates in over 100 countries, reaching 400,000+ practitioners annually through training, and serves a $33 billion total addressable market growing 3%-4% annually.

  • Holds leading positions in chairside, imaging, endodontics, and preventive dental solutions, with over 50 new products launched in four years.

  • Integrated portfolio spans essential dental, orthodontic, implant, and connected technology solutions, with DS Core platform central to connected dentistry strategy.

  • Wellspect business retained for its cash flow contribution and is now managed independently.

  • Connected dentistry strategy leverages technology to streamline workflows and enhance patient-centered care.

Customer-Centric and Innovation Initiatives

  • Shift to a customer-centric mindset, including KOL boards for each segment and doubling clinical education investment to $40 million.

  • Enhanced dentist engagement in R&D, increased sales force education, and expanded dealer networks to improve product fit and market engagement.

  • Accelerated R&D investment, targeting a rise from 4% to 6% of sales, with double-digit R&D growth over 24 months focused on DS Core, implants, and orthodontics.

  • AI and data analytics initiatives to drive efficiency, faster decision-making, and predictive business moves.

  • DS Core platform enables integration with third-party labs and equipment, supporting comprehensive workflows.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more